Mostly Markets
Subscribe
Stocks/Health Care/Health Care Services

Hims & Hers HealthHIMS

Health Care Services
Solid businessPricier than peers
$27.68−6.71%After hours: $27.67 (−0.04%)At the close, 30 Oct · Prices from CNBC, may be delayed
▼ 40.6% over 1 year
Hims & Hers Health over 1 yearDaily close, $, to 30 Oct 2026
$20$30$40Nov2026MarMayJulSep$27.68$20$40NovMarJul$27.68
Source: Nasdaq daily closes
Market value$6.46B
Price to earnings–
Forward P/E73.4x
Dividend yield–
Year to date−14.8%
One year−40.6%
Next earningsMon 9 Nov, after the close
SectorHealth Care
52-week range (closes)
$14.52$45.46

Quality and valuation

How Hims & Hers Health compares with other health care stocks. A description, not a recommendation.

Hims & Hers Health and 5 health care services peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: about averageValuation: pricier than most

An average business among health care companies, priced above most of them.

Hims & Hers Health trades at 73.4 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew faster than the sector median: +28.0% vs +7.8%
  • Keeps more of each sale (gross margin): 68.4% vs 65.3%
  • Less profitable (operating margin): −6.0% vs 13.3%
  • Turns less of its sales into cash: 2.4% vs 15.9%
HIMS trades at 73.4x forward earnings, above the sector medianForward p/e, Health Care Services peers
CI9.4xCVS11.1xDVA11.9xLH19.1xDGX22.2xHIMS73.4xSector median 19.1xCI9.4xCVS11.1xDVA11.9xLH19.1xDGX22.2xHIMS73.4xSector median 19.1x
Source: CNBC quotes; Mostly Markets

Financials

From Hims & Hers Health's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.

Revenue grew 38.2% from a year earlierQuarterly revenue, $m, latest Q2 ’26
$0m$200m$400m$600mQ3 ’24Q1 ’25Q3 ’25$753mQ2 ’26$0m$500mQ3 ’24Q1 ’25Q3 ’25$753mQ2 ’26
Source: SEC filings
Growth sped up to +38.2% last quarterRevenue growth, year on year, %
0%50%100%Q3 ’24Q1 ’25Q3 ’2538.2%Q2 ’260%50%100%Q3 ’24Q1 ’25Q3 ’2538.2%Q2 ’26
Source: SEC filings
Operating margin was -12.9% last quarterOperating income as a share of revenue, %
−10%0%Q3 ’24Q1 ’25Q3 ’25−12.9%Q2 ’26−10%0%Q3 ’24Q1 ’25Q3 ’25−12.9%Q2 ’26
Source: SEC filings
Free cash flow was $62 million over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $m
−$50m$0m$50mQ3 ’24Q1 ’25Q3 ’25−$68mQ2 ’26−$50m$0m$50mQ3 ’24Q1 ’25Q3 ’25−$68mQ2 ’26
Source: SEC filings
Last 12 monthsHIMSSector median
Revenue growth+28.0%+7.8%
Gross margin68.4%65.3%
Operating margin−6.0%13.3%
Free cash flow margin2.4%15.9%

Stories on Hims & Hers Health

We haven't written about Hims & Hers Health yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Services, by market value.

CompanyPriceTodayYTDValue
CVSCVS Health$90.25−0.09%+13.7%$115B
CICigna$298.23−0.06%+8.4%$78.80B
LHLabcorp$361.39−1.84%+44.0%$29.34B
DGXQuest Diagnostics$251.82−0.43%+45.1%$27.70B
DVADaVita$187.50−3.01%+65.0%$11.96B